AbubakrAkhtarBajwaMDFCCP

Pulmonology • Ponte Vedra, FL

Interstitial Lung Diseases, Interventional Pulmonology, Pulmonary Vascular Medicine

Senior Associate Consultant

Join to view full profile

Dr. Bajwa is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bajwa's full profile

Already have an account?

Office
Mayo Clinic, 4500 San Pablo Rd
Ponte Vedra, FL 32082
Is this information wrong?

Education & Training

Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2007
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2005
University of South DakotaResidency, Internal Medicine, 2000 - 2003
King Edward Medical UniversityClass of 1998

Certifications & Licensure

FL State Medical License 2005 - 2025
MN State Medical License 2003 - 2005
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Pulmonary Disease
American Board of Internal Medicine Sleep Medicine
United Council for Neurologic SubspecialtiesNeuro Critical Care

Awards, Honors, & Recognition

Marquis Who's Who in Medicine 2012-2013
Marquis Who's Who 2011-2013

Clinical Trials

Safety Study of Oral Pirfenidone in Patients With Pulmonary Fibrosis/Idiopathic Pulmonary Fibrosis Start of enrollment: 2003 Aug 31
Completed
Phase 2
Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2006 May 01
Completed
Phase 4
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443 Start of enrollment: 2008 Apr 01
Completed
Phase 3
A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2010 Oct 01
Completed
Phase 3
Efficacy and Safety of Pirfenidone in Patients With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2011 Jun 01
Completed
Phase 3
Inhaled Nitric Oxide/INOpulse DS for Pulmonary Arterial Hypertension (PAH) Start of enrollment: 2012 Apr 01
Completed
Phase 2
Impact of Inhaled Treprostinil Sodium on Ventilation Perfusion Matching Start of enrollment: 2011 Nov 01
Terminated
Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1 Start of enrollment: 2012 Dec 01
Completed
Phase 1
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) Start of enrollment: 2013 Jan 31
Terminated
Phase 2
Respicardia, Inc. Pivotal Trial of the remedē System Start of enrollment: 2013 Mar 01
Completed
Not Applicable
Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
Completed
Phase 3
Beraprost-314d Added-on to Tyvaso® (BEAT) Start of enrollment: 2013 May 31
Completed
Phase 3
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE Start of enrollment: 2017 Feb 03
Completed
Phase 2, Phase 3
Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction Start of enrollment: 2017 Aug 15
Terminated
Phase 3
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF Start of enrollment: 2018 Jan 30
Terminated
Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram® Start of enrollment: 2017 Jul 18
Active, not recruiting
Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso Start of enrollment: 2019 Sep 17
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

9 citations
Long-term inhaled treprostinil for pulmonary hypertension due to interstitial lung disease: INCREASE open-label extension study.
Aaron Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Peter Engel, Abubakr Bajwa, Ashwin Ravichandran, Jeremy Feldman, Amy Hajari Case, Rahul G Argula, Victor...> ;The European Respiratory Journal. 2023 Jun 1
1 citations
Pleural Schwannoma Presenting As Musculoskeletal Type Pain: A Case Report.
Ali El-Husari, Hozaifa Tabbaa, Mohamed Ibrahim, Davong D Phrathep, Abubakr Bajwa> ;Cureus. 2023 Apr 1
9 citations
BREEZE: Open-label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hyperten...
Leslie A Spikes, Abubakr A Bajwa, Charles D Burger, Sapna V Desai, Michael S Eggert, Karim A El-Kersh, Micah R Fisher, Shilpa Johri, Joanna M Joly, Jinesh Mehta, Harol...> ;Pulmonary Circulation. 2022 Apr 1
203 citations
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron B. Waxman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Ashwin Ravichandran, Peter A. Engel, Abubakr Bajwa, Roblee P Allen, Jeremy Feldman, Rahul G. Argula, ...> ;The New England Journal of Medicine. 2021 Jan 28
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, ...> ;The New England journal of medicine.
69 citations
Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial
R. James White, Carlos Jerjes-Sánchez, Gisela Martina Bohns Meyer, Tomas Pulido, Pablo Sepúlveda, Kuo Yang Wang, Ekkehard Grünig, Shirish Hiremath, Zaixin Yu, Gangchen...> ;American Journal of Respiratory and Critical Care Medicine. 2020 Mar 15
7 citations
Operator dependent factors implicated in failure of non‐invasive positive pressure ventilation (NIPPV) for respiratory failure
Hammad Bhatti, Avinash Ramdass, James Cury, Lisa Jones, Adil Shujaat, Mariam Louis, Vandana Seeram, Abubakr A. Bajwa> ;The Clinical Respiratory Journal. 2017 Nov 1
4 citations
Association between aspirin use and deep venous thrombosis in mechanically ventilated ICU patients
Ena Gupta, Furqan Siddiqi, Ryan Kunjal, Muhammad Faisal, Farah Al-Saffar, Abubakr A. Bajwa, Lisa Jones, Vandana Seeram, James Cury, Adil Shujaat> ;Journal of Thrombosis and Thrombolysis. 2017 Jul 17
13 citations
The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
Abubakr A. Bajwa, Adil Shujaat, Minal Patel, Colleen S. Thomas, Franck Rahaghi, Charles D. Burger> ;Pulmonary Circulation. 2017 Feb 1
6 citations
Diagnostic accuracy of echocardiography combined with chest CT in pulmonary hypertension
Adil Shujaat, Abubakr A. Bajwa, Farah Al-Saffar, Jason Bellardini, Lisa Jones, James Cury> ;The Clinical Respiratory Journal. 2018 Mar 1
39 citations
A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Ins...
Bradford S. Hoppe, Randal H. Henderson, Dat C. Pham, James Cury, Abubakr A. Bajwa, Christopher G. Morris, Harry J. D'Agostino, S. Flampouri, Soon Huh, Zuofeng Li, Barr...> ;International Journal of Radiation Oncology, Biology, Physics. 2016 May 1
What's new in critical illness and injury science? Pneumonia prevention in the ICU remains a challenge.
Jason Ferreira, Abubakr A. Bajwa> ;International Journal of Critical Illness and Injury Science. 2016 Jan 1
2 citations
Assessment of Pulmonary Arterial Hypertension by Magnetic Resonance Imaging.
El-Sayed H. Ibrahim, Abubakr A. Bajwa, Richard D. White> ;Tomography. 2015 Sep 1
3 citations
Severe Pulmonary Arterial Hypertension: Comprehensive Evaluation by Magnetic Resonance Imaging.
El-Sayed H. Ibrahim, Abubakr A. Bajwa> ;Case Reports in Radiology. 2015 Sep 8
3 citations
Is There Any Association between PEEP and Upper Extremity DVT
Farah Al-Saffar, Ena Gupta, Furqan Siddiqi, Muhammad Faisal, Lisa Jones, Vandana Seeram, Mariam Louis, James Cury, Abubakr A. Bajwa, Adil Shujaat> ;Critical Care Research and Practice. 2015 Apr 2
6 citations
The relationship of intravenous fluid chloride content to kidney function in patients with severe sepsis or septic shock
Faheem W. Guirgis, Deborah J. Williams, Matthew Hale, Abubakr A. Bajwa, Adil Shujaat, Nisha Patel, Colleen Kalynych, Alan E. Jones, Robert L. Wears, Sunita Dodani> ;The American Journal of Emergency Medicine. 2015 Mar 1
2 citations
Predicting the Need for Upfront Combination Therapy in Pulmonary Arterial Hypertension
Abubakr A. Bajwa, Tauseef Qureshi, Adil Shujaat, Vandana Seeram, Lisa Jones, Farah Al-Saffar, James Cury> ;Journal of Cardiovascular Pharmacology and Therapeutics. 2015 Jan 21
3 citations
Use of pulmonary arterial hypertension-specific therapy in non-WHO group I pulmonary hypertension.
Adil Shujaat, Jason Bellardini, James Cury, Abubakr A. Bajwa> ;Southern Medical Journal. 2015 Jan 1
14 citations
Use of endobronchial ultrasound to evaluate nonthrombotic endovascular lesions in pulmonary arteries: a systematic review.
Farah Al-Saffar, Saif Ibrahim, Vandana Seeram, Abubakr A. Bajwa, Adil Shujaat> ;Journal of Bronchology & Interventional Pulmonology. 2015 Jan 1
3 citations
A case of disseminated intravascular coagulation secondary to Acinetobacter lwoffii and Acinetobacter baumannii bacteremia.
Candice Baldeo, Carmen Isache, Cherisse Baldeo, Abubakr A. Bajwa> ;Idcases. 2015 Jan 1
18 citations
Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis.
Muhammad Faisal, Furqan Siddiqi, Ahmad Alkaddour, Abubakr A. Bajwa, Adil Shujaat> ;Pulmonary Medicine. 2014 Nov 16
Use of pulmonary arterial hypertension-specific therapy in overweight or obese patients with obstructive sleep apnea and pulmonary hypertension.
Adil Shujaat, Jason Bellardini, Ankur Girdhar, Abubakr A. Bajwa> ;Pulmonary Circulation. 2014 Jun 1
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King TE Jr Bradford WZ Castro-Bernardini S Fagan EA Glaspole I Glassberg MK Gorina E Hopkins PM Kardatzke D Lancaster L Lederer DJ Nathan SD Pereira CA Sa...> ;N Engl J Med. 2014 May 29
2 citations
Inflammatory pseudotumor of the pleura.
Ankur Girdhar, Amita Singh, Abubakr Bajwa, Adil Shujaat> ;Journal of Bronchology & Interventional Pulmonology. 2014 Apr 1
6 citations
Safety and accuracy of semirigid pleuroscopy performed by pulmonary fellows at a major university hospital: our initial experience.
Adil Shujaat, Abubakr Bajwa, Faisal Usman, Lisa Jones, James Cury> ;Journal of Bronchology & Interventional Pulmonology. 2013 Jul 1
Join now to see all

Journal Articles

Approach to acute exacerbation of idiopathic pulmonary fibrosis
Bhatti M, Girdhar A, Usman A, Cury JD, Bajwa AA, Annals of Thoracic Medicine. 2013; 8 (2);71-77
Characteristics and outcomes of cocaine related spontaneous intracerebral hemorrhages.
Bajwa AA, Silliman S, Cury JD, Jones LM, Shujaat A, Usman F, Samuel V, ISRN Neurology
A rare cause of hypoxia in a patient with liver cirrhosis
Girdhar A, Bajwa AA, Cury JD, Usman F, Resp Med Case Reports. 2012;6:5-6
12. Relationship between pulmonary artery hemodynamics and right ventricle function in pulmonary arterial hypertension using cardiovascular magnetic resonance
El-Sayed I, Bajwa AA, J Cardiovasc Magn Reson 2012, 14(Suppl 1):P82.
Join now to see all